At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 79 enrolled
Drug / intervention
Placebo +1 moredrug
Likely dose
Forceval plus 50 micrograms Vitamin D3from record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Trial of Micronutrient Supplementation in Patients With Heart Failure
In Brief
A Phase 3 clinical trial evaluating Placebo and Forceval plus 50 micrograms Vitamin D3 for Heart Failure. Completed, enrolled 79 participants across 1 site.
Detailed Summary
There is some evidence to suggest that patients with heart failure may have a reduced dietary intake of vitamins and essential minerals (micronutrients) and that this may worsen the function of the heart. This study is designed to investigate if supplementation with micronutrients (including high-dose vitamin D) will improve the function of the heart in patients with heart failure.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure
CountriesUnited Kingdom
Collaborators--
Timeline
Phase 3CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2009
First PostedOct 2009
Primary CompletionAug 2013
Study CompletionJul 2015
TodayJul 2026
First PostedOct 30, 2009
Enrollment StartFeb 1, 2009
Primary CompletionAug 1, 2013
Study CompletionJul 1, 2015
TodayJul 2, 2026
Enrollment to primary: 4.5 yearsPosted 16.7 years ago
Interventions
Placebodrug
1 Tablet Daily
Forceval plus 50 micrograms Vitamin D3drug
Forceval: 1 Tablet Daily; Vitamin D3: 2 Tablets Daily